265 related articles for article (PubMed ID: 23580234)
21. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
22. The Role of Stereotactic Radiosurgery in the Management of Brain Metastases From a Health-Economic Perspective: A Systematic Review.
Warsi NM; Karmur BS; Brar K; Moraes FY; Tsang DS; Laperriere N; Kondziolka D; Mansouri A
Neurosurgery; 2020 Sep; 87(3):484-497. PubMed ID: 32320030
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost-Utility Analysis.
Helou J; Torres S; Musunuru HB; Raphael J; Cheung P; Vesprini D; Chung HT; D'Alimonte L; Krahn M; Morton G; Loblaw A
Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):718-731. PubMed ID: 28916284
[TBL] [Abstract][Full Text] [Related]
24. Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review.
Wang H; Jin C; Fang L; Sun H; Cheng W; Hu S
Cost Eff Resour Alloc; 2020; 18():1. PubMed ID: 31938024
[TBL] [Abstract][Full Text] [Related]
25. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.
Wernicke AG; Yondorf MZ; Parashar B; Nori D; Clifford Chao KS; Boockvar JA; Pannullo S; Stieg P; Schwartz TH
J Neurooncol; 2016 Mar; 127(1):145-53. PubMed ID: 26725100
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases.
Kim H; Rajagopalan MS; Beriwal S; Smith KJ
Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):e157-e164. PubMed ID: 28552517
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of stereotactic body radiotherapy in the treatment of non-small-cell lung cancer (NSCLC): a systematic review.
Sun H; Jin C; Wang H; Hu S; Chen Y; Wang H
Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):723-734. PubMed ID: 35249432
[TBL] [Abstract][Full Text] [Related]
28. Recommended procedures and responsibilities for radiosurgery (SRS) and extracranial stereotactic body radiotherapy (SBRT): report of the SEOR in collaboration with the SEFM.
Conde-Moreno AJ; Zucca Aparicio D; Pérez-Calatayud MJ; López-Campos F; Celada Álvarez F; Rubio Rodríguez C; Fernández-Letón P; Gómez-Caamaño A; Contreras Martínez J
Clin Transl Oncol; 2021 Jul; 23(7):1281-1291. PubMed ID: 33565008
[TBL] [Abstract][Full Text] [Related]
29. Quality and Safety Considerations in Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: An ASTRO Safety White Paper Update.
Das IJ; Dawes SL; Dominello MM; Kavanagh B; Miyamoto CT; Pawlicki T; Santanam L; Vinogradskiy Y; Yeung AR
Pract Radiat Oncol; 2022; 12(4):e253-e268. PubMed ID: 35283342
[TBL] [Abstract][Full Text] [Related]
30. Best of the Radiosurgery Society® Scientific Meeting 2014: stereotactic radiosurgery/stereotactic body radiotherapy treatment of extracranial and intracranial lesions.
Mahadevan A; Bucholz R; Gaya AM; Kresl JJ; Mantz C; Minnich DJ; Muacevic A; Medbery C; Yang J; Caglar HB; Davis JN
Future Oncol; 2014 Dec; 10(15):2307-10. PubMed ID: 25525840
[TBL] [Abstract][Full Text] [Related]
31. The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer: A Comparison of Dose Regimens and Delivery Systems.
Sharieff W; Greenspoon JN; Dayes I; Chow T; Wright J; Lukka H
Technol Cancer Res Treat; 2016 Feb; 15(1):171-8. PubMed ID: 24750007
[TBL] [Abstract][Full Text] [Related]
32. Economic impact of stereotactic radiosurgery for malignant intracranial brain tumors.
Lal LS; Franzini L; Panchal J; Chang E; Meyers CA; Swint JM
Expert Rev Pharmacoecon Outcomes Res; 2011 Apr; 11(2):195-204. PubMed ID: 21476821
[TBL] [Abstract][Full Text] [Related]
33. Refinement of MLC modeling improves commercial QA dosimetry system for SRS and SBRT patient-specific QA.
Hillman Y; Kim J; Chetty I; Wen N
Med Phys; 2018 Apr; 45(4):1351-1359. PubMed ID: 29431865
[TBL] [Abstract][Full Text] [Related]
34. The role of stereotactic body radiotherapy and stereotactic radiosurgery in the re-irradiation of metastatic spinal tumors.
Jain AK; Yamada YJ
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1141-52. PubMed ID: 25066490
[TBL] [Abstract][Full Text] [Related]
35. Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer.
Parthan A; Pruttivarasin N; Davies D; Taylor DC; Pawar V; Bijlani A; Lich KH; Chen RC
Front Oncol; 2012; 2():81. PubMed ID: 22934286
[TBL] [Abstract][Full Text] [Related]
36. The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review.
Wei Q; He H; Lv L; Xu X; Sun W
Transl Androl Urol; 2020 Dec; 9(6):2821-2830. PubMed ID: 33457253
[TBL] [Abstract][Full Text] [Related]
37. Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review.
Rezapour A; Gholampour H; Barzegar M; Irandoust K; Afshari S; Arabloo J; Mahmoodi R; Sarabi Asiabar A; Atefimanesh P; Ghafoori MH
Expert Rev Pharmacoecon Outcomes Res; 2024 May; ():1-24. PubMed ID: 38738558
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB; Grills IS; Kestin LL; Robertson JM
Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.
Li M; Yang X; Chen Y; Yang X; Dai X; Sun F; Zhang L; Zhan C; Feng M; Wang Q
Onco Targets Ther; 2017; 10():2885-2892. PubMed ID: 28652770
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer.
Hodges JC; Lotan Y; Boike TP; Benton R; Barrier A; Timmerman RD
J Oncol Pract; 2012 May; 8(3 Suppl):e31s-7s. PubMed ID: 22942832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
